Tada ... and that BoM2 inventory could also be easily diverted to sales/revenue producing inventory in the short term should the Covid trials go well. 

As much as I want to see BoM2 get underway without further delay, nothing would be better for this company and our stock positions than to actually be approved in one form or another for a specific indication for real world confidence, such as COVID. COVID is Worldwide issue, discussed daily across the world.

Can you imagine the headlines, newfound credibility, revenues stream, and stock appreciation, and negotiating power, at that point ... with a very important and attractive "BTD" BoM2 study right around the corner??

Buy all you want, we'll make more.